Last reviewed · How we verify
Diuretic Therapy
At a glance
| Generic name | Diuretic Therapy |
|---|---|
| Sponsor | University of Texas Southwestern Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Spot Analysis of Natriuresis to Guide up- or Down-titration of Diuretic Therapy in Ambulatory Patients With Chronic Heart Failure (NA)
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (NA)
- ReDS-guided Decongestion Strategy in Patients Hospitalized for Heart Failure (NA)
- Hemodynamic Resuscitation Guided by Non-Invasive Mean Systemic Filling Pressure to Prevent Acute Kidney Injury in Septic Shock (NA)
- POcus INTERvention for Tailoring Diuretic Strategy in Acute Decompensated Heart Failure (PHASE2, PHASE3)
- Clinical Features and Outcomes of CBP Versus Non-CBP in Septic Children
- Outcomes of Urinary Incontinence Treatment in Primary Care: APP Co-Management and Electronic Consult (NA)
- A Practice-Based Intervention To Improve Care for a Diverse Population Of Women With Urinary Incontinence (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Diuretic Therapy CI brief — competitive landscape report
- Diuretic Therapy updates RSS · CI watch RSS
- University of Texas Southwestern Medical Center portfolio CI